16 payers suing over 2027 Medicare Advantage star ratings

Advertisement

At least 16 health insurers have now sued CMS over their 2027 Medicare Advantage star ratings, claiming the agency used quality measures that were never formally adopted through the rulemaking process. Combined, the plans say their current ratings will cost them more than $4.2 billion in lost bonus payments.

Over the last several years, CMS has faced an onslaught of litigation from the industry over how it calculates the ratings, which can lead to millions of dollars in bonuses for high-rated contracts. In 2024, wins by SCAN and Elevance Health led the agency to recalculate ratings for every MA contract, while challenges to the 2025 ratings produced mixed results for the industry.

In May, a federal judge in Georgia ruled that CMS improperly included 20 measures in Clover Health’s 2026 rating, finding the agency lacked authority for 10 of them and skipped notice-and-comment rulemaking for the other 10. CMS raised Clover’s PPO contract from 3.5 to 4.5 stars and recalculated other plans’ ratings, but only where scores would improve and using a different set of measures. CMS’ 2027 MA rule removes 11 measures the agency described as administrative or lacking meaningful variation, mostly starting with the 2029 ratings.

The 16 lawsuits filed so far over the 2027 ratings:

  1. UnitedHealth Group filed Nov. 19 in the Southern District of Georgia, challenging 26 measures across 51 contracts. Fourteen of the challenged measures overlap with those struck down in Clover, and 12 more are challenged on the same grounds. The complaint said 35 of the contracts, serving roughly 2.9 million members, were rated below 4 stars and would qualify for bonus payments if the disputed measures were excluded. Ten contracts would allegedly increase by 1.5 stars, 30 by 1 star and five by half a star. Notably, UnitedHealth did not include its estimated potential monetary losses.

  2. CareFirst BCBS filed Nov. 13 in D.C. federal court, challenging 26 measures across two contracts. One received 2.5 stars and the other 3; CareFirst said those should be 5 and 4, respectively. The Baltimore-based insurer estimated the ratings will cost it roughly $92 million.

  3. Molina Healthcare filed Nov. 13 in D.C. federal court, challenging 14 measures across 16 contracts. Ten of those measures lacked notice-and-comment rulemaking, and four also relied on unauthorized data sources, the complaint alleges. Molina said a recalculation would raise its enterprise-wide weighted average to 3.5 stars and yield roughly $140 million in additional 2028 bonus payments and rebate retention.

  4. UPMC Health Plan also filed Nov. 13 in D.C. federal court, challenging 19 measures for two contracts. One contract received 3.5 stars and the other 3; UPMC said those should be 4 and 3.5, respectively. The plan estimates the difference is roughly $41 million.

  5. Point32Health, parent of Tufts Health Plan and Harvard Pilgrim Health Care, filed Nov. 10 in D.C. federal court, challenging 10 measures on rulemaking grounds. Its two Massachusetts contracts received 4 and 3.5 stars, which it says should have been 4.5 and 4. In total, the insurer estimates roughly $41.4 million is at stake.

  6. Elevance Health filed Nov. 6 in federal court in Washington, D.C., alleging 11 measures had not been adopted through notice-and-comment rulemaking and that two of those relied on Part D claims data outside the data sources statute allows. Elevance said the exclusion of these measures would lift star ratings for 12 contracts, which could yield roughly $516 million in additional 2028 quality bonus payments and rebate retention.

  7. Banner Health, including Banner Health Plan and Banner-University Care Advantage, filed Nov. 6 in D.C. federal court, challenging 17 measures. This included nine from the Clover case and eight additional ones that are “materially indistinguishable and unlawful for the same reasons.” The lawsuit said about $28.3 million in 2028 funding is at stake.

  8. Verda Healthcare filed Nov. 6 in D.C. federal court, alleging 18 measures used data beyond what was authorized. Verda also argued CMS skipped required notice-and-comment rulemaking and acted arbitrarily by assigning star ratings when up to 49% of measures lacked data. The complaint said Verda could lose $20 million in revenue.

  9. Jefferson Health Plans filed Nov. 4 in D.C. federal court. The lawsuit challenged three measures it claims were adopted beyond CMS’ statutory authority and had lacked public notice-and-comment rulemaking. The insurer noted roughly $43 million in lower rebate retention throughout 2028.

  10. BCBS Rhode Island filed Nov. 3 in D.C. federal court, challenging 10 measures in the rating for its single MA contract. The plan received 3.5 stars and said it should have gotten 4.5, and that the difference will cost it roughly $98 million in 2028 bonus payments and rebate retention.

  11. MediGold, the MA arm of Trinity’s Mount Carmel Health System, filed Oct. 30 in the Southern District of Ohio, challenging nine measures on the same rulemaking grounds. MediGold received 3.5 stars for its single contract and said it should have gotten 4, and that the difference will cost it more than $62 million in 2028 bonus payments and rebates.

  12. CVS Health, parent company of Aetna, filed Oct. 26 in the Southern District of Georgia, the same court that ruled against CMS in the Clover case. The suit challenges 28 measures across 43 contracts covering roughly 7 million members. All 28 measures were allegedly adopted without notice-and-comment rulemaking and 12 also relied on data sources outside CMS’ statutory authority. CVS said its enterprise-wide weighted average should be 4.5 stars instead of 4, and that every contract at issue would be at least a half-star higher without the disputed measures. The company estimated the ratings will cost it more than $2 billion in 2028 bonus payments and rebate retention.

  13. SCAN Health Plan also filed Oct. 26, in D.C. federal court, challenging 10 measures on the same rulemaking grounds. Two of the California nonprofit’s contracts received 3.5 stars and two received 4 stars; SCAN said those should be 4 and 4.5, respectively. The plan, which covers more than 435,000 members, said the ratings will deprive it of more than $152 million.

  14. Centene filed Oct. 22 in the Southern District of Georgia, alleging 17 measures were unlawfully adopted, all lacking notice-and-comment rulemaking and six relying on improper data sources. Centene estimated its enterprise-wide average should be 4 stars instead of 3, and that the difference amounts to roughly $448 million in bonus payments and rebates.

  15. Healthfirst filed Oct. 19 in the Southern District of New York, arguing five measures in its rating were never formally adopted through rulemaking. The New York City-based plan dropped from 4.5 stars to 3.5 and said the difference would cost it more than $380 million.

  16. Alignment Healthcare filed suit Oct. 9 in D.C. federal court, challenging the same 10 measures the Clover court found lacked required rulemaking. The insurer said it would lose more than $200 million in 2028 payments as a result of its ratings.
Advertisement

Next Up in Medicare Advantage

Advertisement